While DOACs or warfarin affect coagulation factors that act on both hemostasis and thrombosis ... liver disease or other drugs. A phase 2b trial of abelacimab in patients undergoing total knee ...

BioMedica Diagnostics (BioMedica) is a growing in vitro diagnostics company with core competencies in the field of thrombosis and hemostasis. In addition to providing coagulation products directly ...